This company has been marked as potentially delisted and may not be actively trading. Zogenix (ZGNX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ZGNX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Needle-Free Drug Injection Systems Business Analysis Report 2023-2030 Featuring AKRA Dermojet, Crossject, D`Antonio Consultants, PharmaJet, and ZogenixAugust 1, 2024 | globenewswire.comHwasung Industrial Co Ltd 002460March 23, 2024 | morningstar.comMAlcon (NYSE: ALC)July 6, 2023 | fool.comLongeveron Inc Ordinary Shares - Class AMay 20, 2023 | morningstar.comMHow Women Lead #GetonBoard Week Honorees Are Helping Catapult Fearless Women Leaders into Board Seats - Business WireOctober 11, 2022 | businesswire.comBiocryst PharmaceuticalsSeptember 30, 2022 | forbes.comNippon Shinyaku : Fintepla® (fenfluramine) Approved in Japan for the Treatment of Seizures Associated with Dravet syndrome - Marketscreener.comSeptember 26, 2022 | marketscreener.comMPROMIS NEUROSCIENCES INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.comSeptember 13, 2022 | marketscreener.comMHow Women Lead appoints three new executive board members - Bizwomen - The Business JournalsSeptember 10, 2022 | bizjournals.comEast Bay Biotech Companies - San Francisco Business Times - The Business JournalsSeptember 9, 2022 | bizjournals.comOncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors - PR NewswireSeptember 9, 2022 | prnewswire.comOncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors - StreetInsider.comSeptember 8, 2022 | streetinsider.comOncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors - Yahoo FinanceSeptember 7, 2022 | finance.yahoo.comWith early-cancer detection technology, Delfi Diagnostics looks to beat out Guardant Health, Illumina's Grail and others - San Francisco Business Times - The Business JournalsAugust 30, 2022 | bizjournals.comDepomed Reports Dip in Earnings, Reduces Revenue GuidanceAugust 29, 2022 | thestreet.comDelfi Diagnostics Adds Finance and Market Access Leadership as It Prepares for Commercial Launch - PR NewswireAugust 23, 2022 | prnewswire.comNuvig Therapeutics Expands Leadership Team with the Appointment of Dr. Joanne Quan as Chief Medical Officer - Business WireAugust 16, 2022 | businesswire.comNuvig Therapeutics Expands Leadership Team with the Appointment of Dr. Joanne Quan as Chief Medical Officer - StreetInsider.comAugust 15, 2022 | streetinsider.comDravet Syndrome Treatment Market Report 2022-2029: Stiripentol and Cannabidiol to Contribute to Significant Growth of 11.7% - ResearchAndMarkets.com - Business WireAugust 9, 2022 | businesswire.comTevard Biosciences Appoints Zoya Ignatova to Its Scientific Advisory Board - StreetInsider.comAugust 3, 2022 | streetinsider.comGeno Hires First Chief Legal Officer on Path to Accelerate the Transition to More Sustainable Materials - PR NewswireAugust 2, 2022 | prnewswire.comUCB : Strong first six months – UCB with continued delivery and strong resilience - Marketscreener.comJuly 28, 2022 | marketscreener.comMAdamis Appoints Vickie Reed to Board of Directors - GuruFocus.comJune 25, 2022 | gurufocus.comUCB : updates financial guidance for 2022 while maintaining 2025 financial guidance - Marketscreener.comJune 24, 2022 | marketscreener.comMADARx Pharmaceuticals Expands Leadership Team, Appointing Andrew Seacat as Head of Toxicology - Business WireJune 8, 2022 | businesswire.comUCB's therapy gets FDA orphan drug status to treat seizures linked with rare epilepsy - Seeking AlphaJune 8, 2022 | seekingalpha.comADARx Pharmaceuticals Expands Leadership Team, Appointing Andrew Seacat as Head of Toxicology - StreetInsider.comJune 7, 2022 | streetinsider.comAdamis Appoints Vickie Reed to Board of Directors - StreetInsider.comMay 27, 2022 | streetinsider.comSuneva Medical Inc. Announces Multiple Regulatory Approvals in the U.S. and CanadaMay 5, 2022 | markets.businessinsider.comNorton Rose Adds Brussels Antitrust Pro From Covington - Law360April 19, 2022 | law360.comU.S. FDA approves UCB's drug for rare childhood epilepsy - Marketscreener.comMarch 28, 2022 | marketscreener.comMU.S. FDA approves UCB's drug for rare childhood epilepsy - Reuters.comMarch 28, 2022 | reuters.comForm POS AM ZOGENIX, INC. - StreetInsider.comMarch 7, 2022 | streetinsider.comUCB completes $1.9B acquisition of Zogenix - Seeking AlphaMarch 7, 2022 | seekingalpha.comUCB Completes Acquisition of Zogenix, Inc. - Benzinga - BenzingaMarch 7, 2022 | benzinga.comUCB Completes Acquisition of Zogenix, Inc. - PR NewswireMarch 7, 2022 | prnewswire.comUCB Completes Acquisition of Zogenix, Inc.March 7, 2022 | finance.yahoo.comZogenix : Amendment to Annual Report (Form 10-K/A) - Marketscreener.comMarch 7, 2022 | marketscreener.comMZogenix (Nasdaq:ZGNX) HeadlineTrading was temporarily halted for "ZGNX" at 07:03 PM with a stated reason of "News pending."...March 7, 2022 | marketbeat.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022 - Yahoo FinanceMarch 6, 2022 | finance.yahoo.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN - BenzingaMarch 4, 2022 | benzinga.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022 - StreetInsider.comMarch 4, 2022 | streetinsider.comZogenix To Present New Long-term Data On FINTEPLA (fenfluramine) In Lennox-Gastaut Syndrome (LGS) At AAN 2022 From April 2-7 - BenzingaMarch 4, 2022 | benzinga.comZogenix To Present New Long-term Data on FINTEPLA® - GlobeNewswireMarch 4, 2022 | globenewswire.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022March 4, 2022 | finance.yahoo.comZogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results - Yahoo FinanceMarch 2, 2022 | finance.yahoo.comZOGENIX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K) - Marketscreener.comMarch 1, 2022 | marketscreener.comMUCB Announces Extension of Tender Offer to Acquire Zogenix, Inc. - marketscreener.comMarch 1, 2022 | marketscreener.comMZogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results - GlobeNewswireMarch 1, 2022 | globenewswire.comRecap: Zogenix Q4 Earnings - BenzingaFebruary 28, 2022 | benzinga.com Get Zogenix News Delivered to You Automatically Sign up to receive the latest news and ratings for ZGNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZGNX Media Mentions By Week ZGNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZGNX News Sentiment▼0.200.72▲Average Medical News Sentiment ZGNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZGNX Articles This Week▼00▲ZGNX Articles Average Week Get the Latest News and Ratings for ZGNX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Zogenix and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PRGO News SUPN News PCRX News NKTR News OMER News ASMB News CPIX News LLY News JNJ News ABBV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZGNX) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredOdd “310F trade” doubles investor’s money in just 3 days?Have you heard of 310F? This unusual trade setup has quietly delivered one of the most consistent profit st...Eagle Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZGNX Stock Alerts